Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Nat Immunol

Retrieve available abstracts of 21 articles:
HTML format

Single Articles

    November 2021
  1. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    PubMed     Abstract available

  2. NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.

    October 2021
  3. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    PubMed     Abstract available

    September 2021
  4. TOMALKA JA, Pelletier AN, Fourati S, Latif MB, et al
    The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
    Nat Immunol. 2021 Sep 23. pii: 10.1038/s41590-021-01026.
    PubMed     Abstract available

    Hidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunity.
    Nat Immunol. 2021 Sep 23. pii: 10.1038/s41590-021-01018.

  6. WOLYNN T, Hermann C
    Shots heard round the world: better communication holds the key to increasing vaccine acceptance.
    Nat Immunol. 2021;22:1068-1070.

    Intranasal vaccination.
    Nat Immunol. 2021;22:1071.

  8. ALSUWAIDI AR, Al Hosani FI, ElGhazali G, Al-Ramadi BK, et al
    The COVID-19 response in the United Arab Emirates: challenges and opportunities.
    Nat Immunol. 2021;22:1066-1067.

  9. YAO Y, Chen Z, Zhang H, Chen C, et al
    Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.
    Nat Immunol. 2021;22:1127-1139.
    PubMed     Abstract available

    July 2021
  10. CUPOVIC J, Ring SS, Onder L, Colston JM, et al
    Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00969.
    PubMed     Abstract available

  11. DAI L, Xu K, Li J, Huang Q, et al
    Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00966.
    PubMed     Abstract available

  12. MUKHTAR MM, Khogali M
    The accelerating COVID-19 epidemic in Sudan.
    Nat Immunol. 2021;22:797-798.

    April 2021
  13. CHEN SC
    Taiwan's experience in fighting COVID-19.
    Nat Immunol. 2021;22:393-394.

    March 2021
  14. GEOGHEGAN JL, Moreland NJ, Le Gros G, Ussher JE, et al
    New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Nat Immunol. 2021;22:262-263.

  15. MADKAIKAR M, Gupta N, Yadav RM, Bargir UA, et al
    India's crusade against COVID-19.
    Nat Immunol. 2021;22:258-259.

  16. Coping with COVID.
    Nat Immunol. 2021;22:255.

    January 2021
  17. NELDE A, Bilich T, Heitmann JS, Maringer Y, et al
    SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nat Immunol. 2021;22:74-85.
    PubMed     Abstract available

  18. Challenges for the Biden presidency.
    Nat Immunol. 2021;22:1.

  19. DIVANGAHI M, Aaby P, Khader SA, Barreiro LB, et al
    Trained immunity, tolerance, priming and differentiation: distinct immunological processes.
    Nat Immunol. 2021;22:2-6.

    November 2020
  20. BAHAROM F, Ramirez-Valdez RA, Tobin KKS, Yamane H, et al
    Intravenous nanoparticle vaccination generates stem-like TCF1(+) neoantigen-specific CD8(+) T cells.
    Nat Immunol. 2020 Nov 2. pii: 10.1038/s41590-020-00810.
    PubMed     Abstract available

  21. PENG Y, Mentzer AJ, Liu G, Yao X, et al
    Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
    Nat Immunol. 2020;21:1336-1345.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.